Empirico

Founded: 2017

Location: San Diego, CA

Employee range: 11 - 50

Clinical stage: RD

Therapy area: Cardiometabolic conditions

Drug types: IMM, DRM, CVV, OPH

Lead product: Undisclosed

Product link: https://www.empiricotx.com/

Funding: $17M A-2 Jan 2020; $12.5M A-1 Nov 2018

empiricotx.com

linkedin.com

job board

Short description:

Genetics-Based Drug Discovery

Drug notes:

Additional undisclosed programs RD immune conditions, dermatological conditions, ophthalmic conditions

Long description:

Empirico is using human genetics to create next-generation therapeutics. With advances in DNA sequencing, human genetics can now be employed to gain new biological insights for medicine development. Using this approach with programmable biology, Empirico is powering novel target discovery and development. This involves comparing genetic data with health information from millions of individuals to learn about the role of genes and proteins in health and disease. To facilitate discovery, Empirico uses their Precision Insights PlatformTM, a machine learning platform that can interrogate and prioritize high-confidence therapeutics. Candidates are then validated experimentally in Empirico’s lab.